Renal biopsy findings and followup of renal function in rheumatoid arthritis patients treated with cyclosporin A: An update from the International Kidney Biopsy Registry

Arthritis and Rheumatism

Volumn 39, Issue 9, 1996, Pages 1491-1498

  Rodriguez F ^a   Krayenbuhl J C ^b   Harrison, W B ^b   Forre O ^c   Dijkmans, B A C ^d   Tugwell, P ^e   Miescher, P A ^g   Mihatsch, M J ^f  

^a Sandoz Pharma AG ^*

^b Sandoz Pharma Ltd   (Switzerland)

^c Oslo Sanitetsforening Rheumatism H   (Norway)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF OTTAWA   (Canada)

^f UNIVERSITY HOSPITAL BASEL   (Switzerland)

^g Hôpital Cantonal   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOSPORIN A;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; KIDNEY BIOPSY; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; REGISTER; RHEUMATOID ARTHRITIS;

EID: 0029837228     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390908     Document Type: Article

References (26)

1. Panayi GS, Tugwell P: The use of cyclosporin A in rheumatoid arthritis: conclusions of an international review. Br J Rheumatol 33:967-969, 1994
2. Van Rijthoven AW, Dijkmans BA, Goei Thé HS, Meijers KA, Montnor-Beckers ZL, Moolenburgh JD, Boers M, Cats A: Comparison of cyclosporine and d-pencillamine for rheumatoid arthritis: a randomized, double blind, multicenter study. J Rheumatol 18:815-820, 1991
3. Kruger K, Schattenkirchner M: Cyclosporine A vs azathioprine in the treatment of RA - results of a controlled multicentre double-blind study (abstract). J Autoimmun 5:cxix, 1992
4. Dougados M, Awada H, Amor B: Cyclosporin in rheumatoid arthritis: a double-blind, placebo controlled study in 52 patients. Ann Rheum Dis 47:127-133, 1988
5. Tugwell P, Bombardier C, Gent M, Bennett KJ, Bensen WG, Carette S, Chalmers A, Esdaile JM, Klinkhoff AV, Kraag GR, Ludwin D, Roberts RS: Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis. Lancet 335:1051-1055, 1990
6. Førre Ø, the Norwegian Arthritis Study Group: Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine: results of a 48-week multicenter study comparing low-dose cyclosporine with placebo. Arthritis Rheum 37:1506-1512, 1994
7. Yocum D, Klippel JH, Wilder RL, Gerber NL, Austin HA, Wahl SM, Lesko L, Minor JR, Preuss HG, Yarboro C, Berkebile C, Dougherty S: Cyclosporin A in severe, treatment-refractory rheumatoid arthritis: a randomized study. Ann Intern Med 109:863-869, 1988
8. Tugwell P, Bombardier C, Gent M, Bennett K, Ludwin D, Grace E, Buchanan WW, Bensen WG, Bellamy M, Murphy GF: Low dose cyclosporine in rheumatoid arthritis: a pilot study. J Rheumatol 14:1108-1114, 1987
9. Dougados M, Luchesne L, Awada H, Amor B: Assessment of efficacy and acceptability of low dose cyclosporine in patients with rheumatoid arthritis. Ann Rheum Dis 48:550-556, 1989
10. Madhok R, Torley HI, Capell HA: A study of the longterm efficacy and toxicity of cyclosporine A in rheumatoid arthritis. J Rheumatol 18:1485-1489, 1991
11. Landewé RBM, Goie Thé HS, van Rijthoven AWAM, Breedveld FC, Dijkmans BAC: A randomized, double-blind, 24-week controlled study of low-dose cyclosporine versus chloroquine for early rheumatoid arthritis. Arthritis Rheum 37:637-643, 1994
12. Berg KJ, Førre Ø, Bjerkhoel F, Amundsen E, Djøseland O, Rugdstad HE, Westre B: Side effects of cyclosporin A treatment in patients with rheumatoid arthritis. Kidney Int 29:1180-1187,1986
13. Ludwin D, Bennett KJ, Grace EM, Buchanan WW, Bensen W, Bombardier C, Tugwell P: Nephrotoxicity in patients with rheumatoid arthritis treated with cyclosporine. Transplant Proc 20: 367-370, 1988
14. Ludwin D, Alexopoulou I, Esdaile JM, Tugwell P: Renal biopsy specimens from patients with rheumatoid arthritis and apparently normal renal function after therapy with cyclosporine. Am J Kidney Dis 23:260-265, 1994
15. Kahan BD: Cyclosporine. N Engl J Med 321:1725-1738, 1989
16. Mihatsch MJ, Antonovych T, Bohman SO, Habib R, Heimchen U, Noel LH, Olsen S, Sibley RK, Keneny E, Feutren G: Cyclosporin A nephropathy: standardization of the evaluation of kidney biopsies. Clin Nephrol 41:23-32, 1994
17. Feutren G, Mihatsch MJ: Risk factors for cyclosporin-induced nephropathy in patients with autoimmune diseases. N Engl J Med 326:1654-1660, 1992
18. International Kidney Biopsy Registry of Cyclosporin (Sandimmun®) in Autoimmune Diseases: Renal morphology after cyclosporin A therapy in rheumatoid arthritis patients. Br J Rheumatol 32:65-71, 1993
19. Panayi GS, Tugwell P: An International Consensus Report: the use of Cyclosporin A in rheumatoid arthritis. Br J Rheumatol 32:1-3, 1993
20. Dieterle A, Abeywickrama K, von Graffenried B: Nephrotoxicity and hypertension in patients with autoimmune diseases. Transplant Proc 20:349-355, 1988
21. Sandimmun Product Information. Sandoz Pharma Ltd., Basel, Switzerland
22. Boers M, Croonen AM, Dijkmans BAC, Breedveld FC, Eulderink F, Cats A, Weening JJ: Renal findings in rheumatoid arthritis: clinical aspects of 132 necropsies. Ann Rheum Dis 46:658-663, 1987
23. Boers M, Dijkmans BAC, Breedveld FC, Camps JAJ, Chang PC, van Brummelen P, Pauwels EKJ, Cats A: Subclinical renal dysfunction in rheumatoid arthritis. Arthritis Rheum 33:95-101, 1990
24. Ramirez G, Lambert R, Bloomer HA: Renal pathology in patients with rheumatoid arthritis. Nephron 29:124-126, 1981
25. Boers M: Renal disorders in rheumatoid arthritis. Semin Arthritis Rheum 20:57-68, 1990
26. Sund S, Førre Ø, Berg KJ, Kvien TK, Hovig T: Morphological and functional renal effects of long-term low-dose cyclosporin A treatment in patients with rheumatoid arthritis. Clin Nephrol 41:33-40, 1994